Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per cart...

FDA Recall #D-0593-2024 — Class III — July 2, 2024

Recall #D-0593-2024 Date: July 2, 2024 Classification: Class III Status: Ongoing

Product Description

Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534, Vial NDC: 70710-1644-1, Carton NDC: 70710-1644-5.

Reason for Recall

Cross contamination with other products.

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

8020 vials

Distribution

Nationwide in the USA

Code Information

Lot L300269, Exp Date 07/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated